Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Jean Tang

Professor

Stanford University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Biostatistics Biostatistics professors in United States

Articles (9)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (9)

Cerrene Giordano

Associate Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Daniel Eisen

Professor of Clinical Dermatology

university of california davis medical center

UNITED STATES

View details

Ying Lu

Professor (Curtesy)

Stanford University

UNITED STATES

View details

Fauzia Riaz

Assistant Professor

Stanford University

UNITED STATES

View details

Jennifer Gibson Gill

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Anne Lynn Chang

Professor

Stanford University

UNITED STATES

View details

Anthony Oro

Professor

Stanford University

UNITED STATES

View details

Jiyeong Kim

Assistant Professor

University of California, San Francisco

UNITED STATES

View details

Albert Chiou

Clinical Assistant Professor

Stanford University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean Tang

Research Interests

Explore related searches

Articles (9)

Validation of the Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex

Disseminated coccidioidomycosis with cutaneous, pulmonary and suspected CNS involvement in an elderly patient with Parkinson's disease.

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation.

Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photography.

A Pilot Trial of a Novel Skin Substitute on Chronic and Recurrent Epidermolysis Bullosa Wounds

Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial.

Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care.

Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa.

Clinical Practice Guidelines for the Management of Basal Cell Carcinoma in Gorlin Syndrome

Collaborators (9)

Cerrene Giordano

Daniel Eisen

Ying Lu

Fauzia Riaz

Jennifer Gibson Gill

Anne Lynn Chang

Anthony Oro

Jiyeong Kim

Albert Chiou

Make your next move.